Qi Bin Liang
Technik-/Wissenschafts-/F&E-Leiter bei GENOR BIOPHARMA HOLDINGS LIMITED
Profil
Qi Bin Liang is the founder of CMAB BioPharma (Suzhou) Inc. He is currently working as the Chief Technology Officer at Genor Biopharma Holdings Ltd.
He completed his graduate degree from the University of Idaho and his undergraduate degree from East China University of Science & Technology.
Aktive Positionen von Qi Bin Liang
| Unternehmen | Position | Beginn |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
CMAB BioPharma (Suzhou) Inc.
 CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Gründer | - |
Ausbildung von Qi Bin Liang
| University of Idaho | Graduate Degree |
| East China University of Science & Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CMAB BioPharma (Suzhou) Inc.
CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Commercial Services |